☰

Brian Matthew Zeglis

Affiliations: 
Hunter College of the City University of New York, New York, NY, United States 
Area:
Radiopharmaceutical Chemistry
Google:
"Brian Zeglis"
Mean distance: (not calculated yet)
 
Tree Publications Similar researchers PubMed Report error

Parents

Sign in to add mentor
Robert H. Crabtree research assistant 2001-2004 Yale
Jacqueline K. Barton grad student 2004-2009 Caltech
Jason S. Lewis post-doc 2009-2015 Memorial Sloan Kettering Cancer Center

Children

Sign in to add trainee
Outi Keinänen post-doc 2018- Hunter College (CUNY)
Aaron G Nash post-doc 2020- Hunter College, CUNY

Collaborators

Sign in to add collaborator
BETA: Related publications

Publications

You can help our author matching system! If you notice any publications incorrectly attributed to this author, please sign in and mark matches as correct or incorrect.

Yeh R, O'Donoghue JA, Jayaprakasam VS, et al. (2024) First-in-Human Evaluation of Site-Specifically Labeled Zr-Pertuzumab in Patients with HER2-Positive Breast Cancer. Journal of Nuclear Medicine : Official Publication, Society of Nuclear Medicine
Bauer D, Cornejo MA, Hoang TT, et al. (2023) Click Chemistry and Radiochemistry: An Update. Bioconjugate Chemistry
Delaney S, Rodriguez C, Sarrett SM, et al. (2023) Unraveling the in vivo fate of inhaled micro- and nanoplastics with PET imaging. The Science of the Total Environment. 904: 166320
Delaney S, Sebastiano J, Zeglis BM, et al. (2023) Molecular Imaging, Radiochemistry, and Environmental Pollutants. Journal of Nuclear Medicine : Official Publication, Society of Nuclear Medicine
Keinänen O, Sarrett SM, Delaney S, et al. (2023) Visualizing Galectin-3 Binding Protein Expression with ImmunoPET. Molecular Pharmaceutics
Bauer D, Sarrett SM, Lewis JS, et al. (2023) Click chemistry: a transformative technology in nuclear medicine. Nature Protocols
Zeglis BM, Lewis JS. (2022) Click Here for Better Chemistry. The New England Journal of Medicine
MacPherson DS, Hwang D, Sarrett SM, et al. (2022) Leveraging a Dual Variable Domain Immunoglobulin to Create a Site-Specifically Modified Radioimmunoconjugate. Molecular Pharmaceutics
Feng Y, Sarrett SM, Meshaw RL, et al. (2022) Site-Specific Radiohalogenation of a HER2-Targeted Single-Domain Antibody Fragment Using a Novel Residualizing Prosthetic Agent. Journal of Medicinal Chemistry
Sarrett SM, Rodriguez C, Rymarczyk G, et al. (2022) Lysine-Directed Site-Selective Bioconjugation for the Creation of Radioimmunoconjugates. Bioconjugate Chemistry
See more...